Efficacy and safety of cycpofol combined with remifentanil in patients undergoing laparoscopic colon cancer surgery: a prospective, randomized, double-blind, non-inferiority trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300067398

Enrollment

Unknown

Registered

2023-01-06

Start date

2023-01-09

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Anesthesia

Interventions

Group 1:Cycpofol

Group 2:Propofol

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The patients who received general anesthesia, ASA grade I-III, 18 years old < age < 80 years old, BMI < 30 kg/m2, liver and kidney function were normal.

Exclusion criteria

Exclusion criteria: Previous history of anesthetic allergy and contraindications; long-term history of opioid use; cognitive impairment; family members or patients themselves refused.

Design outcomes

Primary

Measure	Time frame
QoR15 score;Anesthetic adverse reaction;	—

Secondary

Measure	Time frame
Operation time;Intraoperative bleeding volume;Anaesthesia time;Awakening time;Extubation time;Postoperative pain score;	—

Countries

China

Contacts

Public ContactWu Yu

The 980th Hospital Of Joint Logistics Support Force

vwuyuv@163.com+86 186 3348 7638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026